Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 6Unknown 3Not yet recruiting 3Recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Pneumonia 1Neoplasms 1Lung Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × pirfenidone × Clear all
NCT05801133 2024-03-15

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

Hubei Cancer Hospital

Phase 2 Unknown
41 enrolled
Thoracic

Lung Neoplasms

NCT06142318 2023-11-21

Pirfenidone as a Radiosensitizer in the Treatment of Head and Neck Squamous Cell Carcinoma

Nanfang Hospital, Southern Medical University

Phase 2 Unknown
66 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05280873 2022-03-15

Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP

Guangzhou Institute of Respiratory Disease

Phase 1 Unknown
48 enrolled

Neoplasms, Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡